Skip to content

A randomized parallel controlled clinical trial for platelet-rich plasma and hyaluronic acid injection in the treatment of temporomandibular arthritis

A randomized parallel controlled clinical trial for platelet-rich plasma and hyaluronic acid injection in the treatment of temporomandibular arthritis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023013
Enrollment
Unknown
Registered
2019-05-07
Start date
2019-05-20
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

temporomandibular arthritis

Interventions

experimental group :1 ml PRP was injected into the superior cavity of the affected temporomandibular joint. The total course of treatment included 2 injections, with an interval of 2 weeks (14 days)
control group:1 ml sodium hyaluronate was injected into the upper cavity of the affected temporomandibular joint. The total course of treatment included two injections, with an interval of 2 weeks (14

Sponsors

Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Subjects: Temporomandibular Osteoarthritis (TMJ-OA) patients with TMD Diagnostic Classification III B (arthralgia + articular frictional sounds or imaging changes) Aged 18-60 years; Men and women are not limited; Outpatient patients; CBCT confirmed TMD-OA patients with imaging changes before admission; Sign informed consent.

Exclusion criteria

Exclusion criteria: Other clinical trials were conducted within 4 weeks before the start of this study; Patients who underwent joint lavage or intra-articular injection within 2 weeks before the start of this study; Non-steroidal anti-inflammatory drugs were administered within one week before treatment; Septicemia, severe thrombocytopenia, platelet dysfunction; Infection of articular region; Previous TMJ surgery for patients; Patients with neurological diseases, immune system diseases, tumors and other attending physicians who do not consider them suitable for inclusion in the study; Cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Efficiency of pain improvement;

Secondary

MeasureTime frame
Maximum opening and mandibular movement;clicking of mandibular joints;CBCT Imaging;Activity of daily living;

Countries

China

Contacts

Public ContactXu Lili

Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine

heblll@163.com+86 18221878206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026